Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorChanghai Hospital

About this trial

The pathological biopsy of gastric lesions, performed prior to endoscopic submucosal dissection (ESD), is crucial for differentiating the pathological nature of the lesions and guiding treatment decisions. However, due to the impact of biopsy sampling, the sensitivity of the pathological biopsy is not optimal.

The probe - based confocal laser endomicroscopy (pCLE) technique enables the real - time display of high-resolution microscopic images of the mucosal layer (with an amplification factor of up to 1000 times) through a slender optical fiber probe that can pass through the standard endoscope's working channel. It is an optical biopsy technique and has unique value in determining the pathological nature of gastric lesions.

As the Digestive Endoscopy Center of Shanghai Changhai Hospital is a national-level pCLE application demonstration center, it has prospectively collected numerous cases of pCLE examinations of gastric mucosal lesions.

The main purpose of this study is to retrospectively analyze these cases and compare the sensitivity and specificity of pathological biopsy and pCLE in differentiating the pathological nature of gastric mucosal lesions.

Eligibility criteria

Qualifiers

All patients aged 18-75 who underwent pCLE examination and received ESD treatmen.

Disqualifiers

lack of pre-ESD pathological biopsy results, and ESD pathology indicated advanced gastric cancer.

Trial design

Treatments tested in this trial

  • Probe-based Confocal Laser Endomicroscopy
  • Pathological biopsy

Treatment groups

No treatment groups listed

Sponsors and collaborators